In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn: Why Landon left Medtronic Where Philips fits into medtech’s future How Philips hopes to expand Will Philips […]
Merit Medical Systems
The top 5 MassDevice stories of the week — October 23, 2020
The U.S. presidential election is top of mind for many people, but medtech news continued to roll out on MassDevice this past week. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” — as try out new, “exciting” sound effects — during […]
Merit Medical settles physician kickback suit for $18M
Merit Medical (NSDQ:MMSI) recently agreed to pay $18 million to resolve allegations that the company paid kickbacks to physicians to use its embolization and occlusion products. Whistleblower and former Merit chief compliance officer Dr. Charles Wolf alleged in a civil suit that the Salt Lake City-based company paid doctors and hospitals to use more of its […]
MedTech 100 roundup: Another rebound as markets continue to fluctuate
Medtech stocks rebounded from a significant dip earlier in June last week, continuing to highlight the topsy-turvy nature of the markets during the COVID-19 pandemic. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 85.00 points at the end of last week (June 19). That total represents […]
Former Merit Medical executive claims physician kickbacks in whistleblower lawsuit
The U.S. has joined in a whistleblower lawsuit filed by the former chief compliance officer of Merit Medical (NSDQ:MMSI), who claims the company ran a fraud scheme involving physician kickbacks. Dr. Charles Wolf alleges the Salt Lake City-based medical device company engaged in unlawful kickbacks to induce physicians to use more of its Embosphere and QuadraSphere […]
Merit Medical lands CE mark for Wrapsody endovascular stent graft
Merit Medical (NSDQ:MMSI) announced that it received CE Mark approval in Europe for its Wrapsody endovascular stent graft system. Wrapsody is a flexible, self-expanding endoprosthesis indicated for use in hemodialysis patients for treating stenosis or occlusion within central veins, along with the dialysis outflow circuit of an arteriovenous (AV) fistula or AV graft, according to a […]
Merit Medical wins FDA breakthrough nods
Merit Medical (NSDQ:MMSI) systems announced that it won two additional breakthrough device designations from the FDA for its Wrapsody endovascular stent graft system. Wrapsody is designed as a flexible, self-expanding endoprosthesis and won a breakthrough nod in November 2019 for hemodialysis treatment. Its latest indications include treating stenosis or occlusion within the dialysis outflow circuit, including […]
Merit Medical lands breakthrough designation for dialysis stent graft system
Merit Medical (NSDQ:MMSI) announced last week that it has been granted FDA breakthrough device designation for its Wrapsody endovascular stent graft system. Wrapsody is a flexible, self-expanding endoprosthesis designed for hemodialysis patients. Merit said it will seek indication to treat stenosis within the central veins of the outflow circuit of an arteriovenous fistula (AVF) up […]
Merit Medical closes $50m BrightWater buyout
BrightWater Medical said today that it completed the sale of the organization to Merit Medical (NSDQ:MMSI), three months after Merit made its $50 million offer. In June, Merit valued the acquisition at $35 million upfront with a further $15 million in potential payments contingent upon CE Mark approval and meeting future sales targets. Temecula, Calif.-based BrightWater’s […]
Merit Medical plunges on Q2 miss, lowered outlook
Merit Medical (NSDQ:MMSI) shares lost more than a quarter of their value today after the medical device maker missed the consensus for its second-quarter sales and earnings and lowered its outlook on the rest of the year. South Jordan, Utah-based Merit posted profits of $6.9 million, or 12¢ per share, on sales of $255.5 million for […]
Merit puts $50m on the table for Brightwater
Merit Medical (NSDQ:MMSI) said this week that it plans to acquire Brightwater Medical in a deal valued at $50 million. Temecula, Calif.-based Brightwater Medical’s lead product, ConvertX, is a device designed to treat severe obstructions of the ureter. The company recently won FDA clearance for its ConvertX biliary stent system, according to Merit Medical. The deal […]
